3,4-methylenedioxyethamphetamine has been researched along with Rhabdomyolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korten, JJ; Roebroek, RM | 1 |
| Centini, F; Fineschi, V; Mazzeo, E; Turillazzi, E | 1 |
2 other study(ies) available for 3,4-methylenedioxyethamphetamine and Rhabdomyolysis
| Article | Year |
|---|---|
[Epileptic insults, cerebral infarction and rhabdomyolysis as complications of amphetamine use].
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Cerebral Infarction; Designer Drugs; Epilepsy, Generalized; Humans; Male; Rhabdomyolysis; Substance-Related Disorders | 1996 |
Adam (MDMA) and Eve (MDEA) misuse: an immunohistochemical study on three fatal cases.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Disseminated Intravascular Coagulation; Fatal Outcome; Forensic Medicine; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Male; Myoglobinuria; N-Methyl-3,4-methylenedioxyamphetamine; Rhabdomyolysis | 1999 |